Gemayel Lee, MD
Pain Medicine · San Diego, CANPI 1265772537
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $79,459 of the $131,290 with a category attached, or 60.5%. SPR Therapeutics, Inc accounts for 92.4% of it on its own, with 38 other manufacturers making up the rest. Reporting peaked in 2023 at $63,281 and has fallen 56.0% since, to $27,822 in 2025. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 410 payments — averaging $320.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SPR Therapeutics, Inc$121K
- Boston Scientific$3K
- Abbott$2K
- Nevro Corp.$1K
- Medtronic$1K
- Curonix LLC$614
- plus $3K from 33 others
What the payments were for
- Consulting fees$79,45961%
- Travel & lodging$35,49027%
- Food & beverage$16,34212%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$118,683
- INTELLIS ADAPTIVESTIM$666
- WAVEWRITER ALPHA$469
- WaveWriter Alpha Prime 16$458
- Senza Spinal Cord Stimulation System$424
- Proclaim Family of SCS IPGs$404
- GENERAL PAIN MANAGEMENT$392
- Omnia$277
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$266
- Nalu Neurostimulation System$255
- Qutenza$228
- ETERNA$171
- Prodigy Family of SCS IPGs$160
- Nexwave$130
- iFuse Implant$119
- PROCLAIM$114
How this compares
$131,290 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $561 |
| Gabapentin | 31 | $223 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $214 |
| Cyclobenzaprine Hcl | 15 | $20 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in San Diego
- Nathaniel SchusterSan Diego$337K
- Mark WallaceSan Diego$221K
- Jessica OswaldSan Diego$90K
- Zachary CohenSan Diego$36K
- Joel CastellanosSan Diego$30K
- David HillerSan Diego$30K
- Seth KatzenSan Diego$29K
- Jason PopeSanta Rosa$2.1M
- Ramana NaiduLarkspur$1.4M
- Foead GeulaStudio City$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.